PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 47 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

4 April 2025

  1. (diff | hist) m 08:56 Active pharmaceutical ingredient 3,553 +118 MicrodoseMagnus (talk | contribs) correct the description of the research-use-only exemption [rollback]
  2. (diff | hist) m 07:48 Lyophilisation 20,027 +147 TrialsTabitha (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  3. (diff | hist) 04:49 Crude peptide 3,916 ±0 PancreasPru (talk | contribs) ce per PP:MOS [rollback]

3 April 2025

  1. (diff | hist) 21:52 Xi'an Mokemei Biotechnology 2,374 ±0 COA_Colwyn (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 20:14 Area percent purity 6,569 ±0 StabilityStig (talk | contribs) space between number and unit per PP:MOS [rollback]
  3. (diff | hist) 14:07 Talk:Shanghai Wibson Biotechnology 748 +179 AnalyticalAnnie (talk | contribs) /* A shorter registry history is not a finding */ reply
  4. (diff | hist) 12:20 Counterfeit peptide 3,976 +98 ForgeryFinder (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  5. (diff | hist) 10:22 Talk:Shanghai Wibson Biotechnology 537 +213 UnderfillUna (talk | contribs) /* A shorter registry history is not a finding */ new section
  6. (diff | hist) 08:00 Flourishglobal Peptide Biotech 4,681 +1,087 MarginNoteMars (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  7. (diff | hist) 03:21 Albumin binding half-life extension 4,872 ±0 EmptyingElke (talk | contribs) ce per PP:MOS [rollback]

2 April 2025

  1. (diff | hist) 19:16 Oral semaglutide 3,542 +23 ExenatideEzra (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  2. (diff | hist) m 08:59 SELECT trial 4,206 ±0 TrialsTabitha (talk | contribs) add the DOI [rollback]
  3. (diff | hist) 08:57 Talk:Multi-dose vial 1,170 +250 StopperingSteff (talk | contribs) /* Merge proposal from Vial — response */ reply
  4. (diff | hist) 05:38 Global access disparity 2,619 ±0 Chromatokid (talk | contribs) attribute the survey figure to the survey and give its sample size [rollback]
  5. (diff | hist) 00:48 Third-party testing 5,770 ±0 BetaCellBoyd (talk | contribs) typo [rollback]

1 April 2025

  1. (diff | hist) 21:35 Insulin syringe 4,111 ±0 DiluentDiya (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  2. (diff | hist) m 21:16 Haemoglobin A1c 3,366 ±0 B12_Bettina (talk | contribs) state which fraction the assay actually measures [rollback]
  3. (diff | hist) m 18:28 LEADER trial 3,537 ±0 UnitsUrsula (talk | contribs) split the results table so the two doses are separate rows [rollback]
  4. (diff | hist) 14:33 International nonproprietary name 3,145 ±0 Chromatokid (talk | contribs) split overlong sentence [rollback]
  5. (diff | hist) 13:48 Good manufacturing practice 3,919 +371 IsocraticIla (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]
  6. (diff | hist) m 12:55 GLP-1 receptor 6,418 +313 TirzTaxonomist (talk | contribs) expand §Distribution and its clinical consequences [rollback]
  7. (diff | hist) m b 09:59 Weight regain after discontinuation 4,031 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  8. (diff | hist) m 06:17 Receptor bias 3,536 +19 EmptyingElke (talk | contribs) expand §The concept [rollback]
  9. (diff | hist) 04:08 Chinese Peptide Company 10,512 +526 AnalyticalAnnie (talk | contribs) add the reception tally with its period and count stated [rollback]
  10. (diff | hist) m 00:53 Peptide synthesis 4,113 ±0 TechnicianTeal (talk | contribs) fix the anchor on an internal link [rollback]

31 March 2025

  1. (diff | hist) m b 20:38 Tianjin Finder Chemical 6,862 +249 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  2. (diff | hist) m b 20:32 Beyond-use date 13,114 +1,020 CategoryBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 16:33 Reconstitution of lyophilised peptides 4,389 ±0 HyphenHarriet (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  4. (diff | hist) 15:51 Batch number 3,708 ±0 LotTraceLuka (talk | contribs) expand §Assignment [rollback]
  5. (diff | hist) 10:58 Contraindications of incretin therapy 4,296 +726 HypoHildur (talk | contribs) add the perioperative consideration with the society guidance it comes from [rollback]
  6. (diff | hist) 09:43 Amylin 4,252 ±0 Retention_Time_Rae (talk | contribs) serial comma per PP:MOS [rollback]
  7. (diff | hist) m 00:52 Solid-phase peptide synthesis 5,076 ±0 API_Aurora (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]

30 March 2025

  1. (diff | hist) 20:52 Exenatide 4,288 ±0 CagriCass (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 18:44 SURMOUNT trial programme 3,559 ±0 GastroparesisGwen (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  3. (diff | hist) 15:14 MOTS-c 3,248 +552 EpitalonEoin (talk | contribs) split the pharmacology section from the marketing history [rollback]
  4. (diff | hist) 12:11 GL Biochem (Shanghai) 12,967 +1,223 LotTraceLuka (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  5. (diff | hist) 11:28 Patent expiry and biosimilars 3,211 +38 BiliaryBea (talk | contribs) add the effective date to the regulatory table [rollback]
  6. (diff | hist) m 09:24 Mass spectrometry 5,223 ±0 NewLabNell (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  7. (diff | hist) m 07:38 Triple agonist 3,428 ±0 CuriousCallum (talk | contribs) copyedit [rollback]
  8. (diff | hist) 06:46 Customs seizure 3,147 +133 API_Aurora (talk | contribs) rm the claim that the position has changed; no source supports it [rollback]
  9. (diff | hist) m 06:02 Research use only 6,689 ±0 LiraLotte (talk | contribs) expand §Legal position and importation [rollback]
  10. (diff | hist) m 02:22 Vial 18,279 +550 StopperingSteff (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  11. (diff | hist) m 01:54 Baseline laboratory panel 3,039 ±0 Chromatokid (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  12. (diff | hist) m 00:28 Shanghai Sigma-Audley New Material Technology 7,523 ±0 ForgeryFinder (talk | contribs) sentence case in headings per PP:MOS [rollback]

29 March 2025

  1. (diff | hist) m b 23:00 USP General Chapter 71 3,363 +271 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) 21:57 Sarcopenia 3,440 +121 SecondarySrc_Seb (talk | contribs) state the fasting requirement explicitly [rollback]
  3. (diff | hist) 19:50 Analytical method validation 4,442 ±0 Areapercent_Ayo (talk | contribs) fix indentation in the source [rollback]
  4. (diff | hist) 18:13 Chain of custody 4,085 ±0 SemaxSevi (talk | contribs) add the cross-link to the traceability article [rollback]
  5. (diff | hist) m 15:09 Drug master file 3,180 ±0 FiveOhThreeB (talk | contribs) add the note that this wiki does not give legal advice [rollback]
  6. (diff | hist) m 11:11 Bacterial endotoxin test 4,398 ±0 PreregPriya (talk | contribs) British spelling per PP:MOS [rollback]
  7. (diff | hist) m 09:39 Contract development and manufacturing organisation 3,804 +220 RepackRadek (talk | contribs) alphabetise the see-also list [rollback]
  8. (diff | hist) 08:44 Talk:Multi-dose vial 1,033 +86 BUD_Bertram (talk | contribs) /* The 28-day rule is being cited as a stability figure */ reply
  9. (diff | hist) 06:36 Amylin receptor agonist 3,909 ±0 CuriousCallum (talk | contribs) ce [rollback]
  10. (diff | hist) m 02:58 Trifluoroacetate counterion 3,899 +410 LOD_Lorcan (talk | contribs) fix the anchor on an internal link [rollback]

28 March 2025

  1. (diff | hist) 13:54 Grey market 2,605 +29 SupplyWatchSuri (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  2. (diff | hist) 10:27 Lixisenatide 3,215 ±0 ComparisonCato (talk | contribs) expand §Current position [rollback]
  3. (diff | hist) 09:26 Talk:Multi-dose vial 822 +195 StabilityStig (talk | contribs) /* The 28-day rule is being cited as a stability figure */ reply
  4. (diff | hist) 09:15 Xi'an Mokemei Biotechnology 2,374 +38 ChainCustodyChad (talk | contribs) expand §External links [rollback]
  5. (diff | hist) 08:54 WuXi TIDES 10,186 ±0 MassSpecMarv (talk | contribs) split §Operations from §Product range [rollback]
  6. (diff | hist) 06:05 Dipeptidyl peptidase-4 6,022 +259 LCellLeif (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]
  7. (diff | hist) 04:41 Purity claim inflation 4,595 +872 ForgeryFinder (talk | contribs) expand §Reading against inflation [rollback]
  8. (diff | hist) 04:10 Peptide harm reduction 3,320 ±0 TierTwoTansy (talk | contribs) expand §What documentation can and cannot fix [rollback]
  9. (diff | hist) 03:12 Qingdao Sigma Chemical 10,302 +1,069 CheckSumChase (talk | contribs) add the catalogue size and label it self-reported [rollback]

27 March 2025

  1. (diff | hist) 21:55 Amino acid analysis 3,703 +121 TFA_Counterion (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  2. (diff | hist) 13:52 Talk:Multi-dose vial 611 +390 EndotoxinEd (talk | contribs) /* The 28-day rule is being cited as a stability figure */ reply
  3. (diff | hist) 12:36 Number needed to treat 3,631 ±0 Ref_Desk_Ron (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  4. (diff | hist) 10:18 Talk:Multi-dose vial 400 +302 BUD_Bertram (talk | contribs) /* The 28-day rule is being cited as a stability figure */ new section
  5. (diff | hist) m b 04:20 Underfilling 3,398 +878 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 03:56 Reconstitution calculator 6,007 +731 SchemaSorcha (talk | contribs) add the citation for the stability figures taken from the labelling [rollback]

26 March 2025

  1. (diff | hist) m 23:15 Liquid chromatography-mass spectrometry 3,724 +273 LabRangeLindy (talk | contribs) add the reference standard and its traceability [rollback]
  2. (diff | hist) 22:20 Tirzepatide 6,329 ±0 NNT_Nerys (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  3. (diff | hist) 22:12 SURPASS trial programme 3,958 ±0 LeaderLoic (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 21:56 Body composition assessment 4,164 +104 ApoB_Aurelio (talk | contribs) state the fasting requirement explicitly [rollback]
  5. (diff | hist) 21:56 Deamidation 4,219 +22 AnalyticalAnnie (talk | contribs) expand §Detection [rollback]
  6. (diff | hist) 19:27 Satiety signalling 4,441 ±0 ProglucagonPia (talk | contribs) expand §Central integration [rollback]
  7. (diff | hist) 19:18 Certificate of analysis 6,972 ±0 ChainCustodyChad (talk | contribs) correct the description of the sampling procedure [rollback]
  8. (diff | hist) m b 19:13 Dual incretin agonist 4,734 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  9. (diff | hist) m 16:40 Glucose-dependent insulinotropic polypeptide 6,686 ±0 LabelLibby (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  10. (diff | hist) m 11:46 Adverse effects of GLP-1 receptor agonists 5,297 +602 SarcopeniaSefa (talk | contribs) expand §Body composition and other effects [rollback]
  11. (diff | hist) 10:05 Talk:Multi-dose vial 959 +227 EndotoxinEd (talk | contribs) /* Merge proposal from Vial — response */ reply
  12. (diff | hist) 08:40 Talk:Peptide content 959 +204 ReportReaderRilla (talk | contribs) /* Which convention does a nominal fill follow? */ reply
  13. (diff | hist) 04:53 HOMA-IR 3,431 ±0 CPeptidePaddy (talk | contribs) add the citation for the imprecision figure [rollback]
  14. (diff | hist) m 03:58 Shanghai Wibson Biotechnology 5,661 +153 EscalationEira (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  15. (diff | hist) m 03:51 High-performance liquid chromatography 6,011 +647 COA_Colwyn (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]

25 March 2025

  1. (diff | hist) 23:36 USP General Chapter 85 4,270 +689 TitrationTheo (talk | contribs) add the repeatability figure with the number of injections [rollback]
  2. (diff | hist) 13:56 Glucagon-like peptide-1 10,239 ±0 GIP_Genoveva (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  3. (diff | hist) m 13:36 Trial data comparison 3,217 +43 CoI_Corin (talk | contribs) add keyboard operation to the control description [rollback]
  4. (diff | hist) 13:23 Orforglipron 4,165 +109 Chromatokid (talk | contribs) expand §Reported clinical findings [rollback]
  5. (diff | hist) 13:21 Talk:Peptide content 748 +234 AnalyticalAnnie (talk | contribs) /* Which convention does a nominal fill follow? */ reply
  6. (diff | hist) 12:41 Talk:Multi-dose vial 748 +290 SyringeSybille (talk | contribs) /* Merge proposal from Vial — response */ reply
  7. (diff | hist) 12:14 SUSTAIN trial programme 4,187 ±0 TimelineTiernan (talk | contribs) expand §Relationship to the obesity programme [rollback]
  8. (diff | hist) m b 11:20 Missed dose 4,407 +284 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  9. (diff | hist) 09:55 Talk:Peptide content 537 +176 UnderfillUna (talk | contribs) /* Which convention does a nominal fill follow? */ new section
  10. (diff | hist) 09:33 Talk:Multi-dose vial 537 +402 StopperingSteff (talk | contribs) /* Merge proposal from Vial — response */ new section
  11. (diff | hist) 07:38 Multi-dose vial 10,398 +2,966 EscalationEira (talk | contribs) add the diluent volume the example assumes [rollback]
  12. (diff | hist) m b 05:27 Methionine oxidation 3,582 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  13. (diff | hist) 03:59 Growth hormone secretagogue 3,576 +143 TesamorelinTeg (talk | contribs) move the vendor-availability paragraph out; that is not article material [rollback]
  14. (diff | hist) 02:54 Glossary of peptide terminology 4,571 +990 BaselineBex (talk | contribs) expand §Analysis and documentation [rollback]
  15. (diff | hist) 01:08 Beta cell function 4,916 ±0 LipidLedgerLou (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]

24 March 2025

  1. (diff | hist) m 15:07 Prior authorisation 3,094 +844 Hedgerow_Hal (talk | contribs) rm the advice on how to obtain coverage [rollback]